For the past five years, ViiV Healthcare (a global specialist HIV company) has been collaborating with the University of North Carolina at Chapel Hill.
Together, the two entities have been focused on discovering a cure for HIV. In March this year, the two announced that they would renew their partnership for another five-year stint.
Through bringing together academic and industrial expertise, this $20m collaboration aims to develop an entirely new therapeutic approach to the virus. “The collaboration was founded out of the idea that we would likely not make progress toward curing HIV as individuals and that together we stood a better chance to move forward,” says Richard Dunham, director of HIV Cure at ViiV Healthcare. “The partnership